In short
This article discusses a clinical trial investigating the effectiveness of Beltavac® with a polymerized extract of grass pollen mixture for treating allergic rhinoconjunctivitis, with or without asthma. The study aims to determine the optimal therapeutic dose of the medication administered in a rush regimen, focusing on its impact on symptoms and medication use during pollen season.
At a glance
- Study Type
- Randomized, double-blind, placebo-controlled clinical trial
- Medication
- Beltavac® with polymerized extract of grass pollen mixture
- Condition
- Allergic rhinoconjunctivitis (with or without asthma)
- Main Objective
- Establish optimal therapeutic dose
- Secondary Objective
- Assess impact on symptoms and medication use during pollen season
- Treatment Groups
- 1) Beltavac® 2RC/ml, 2) Beltavac® 5RC/ml, 3) Placebo
- Administration
- Rush regimen followed by monthly injections
- Primary Endpoint
- Change in reactivity to Conjunctival Provocation Test
- Secondary Endpoints
- Symptom scores, medication use during peak pollen season
What is Beltavac?
Beltavac is an innovative immunotherapy treatment designed to help patients suffering from grass pollen allergies. It contains a polymerized extract of grass pollen mixture, which includes five common grass species: Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense, and Poa pratensis. These grasses are often responsible for triggering allergic reactions in many individuals during the pollen season.
How Does Beltavac Work?
Beltavac works by gradually exposing your immune system to small amounts of grass pollen allergens. This exposure helps your body build tolerance to these allergens over time, reducing your allergic reactions when you encounter grass pollen in your environment. The polymerized form of the allergen extract in Beltavac means that the allergens have been chemically modified to make them safer and more effective for immunotherapy.
Medical Conditions Treated
Beltavac is specifically designed to treat:
- Allergic rhinoconjunctivitis: This condition involves inflammation of the nose and eyes due to an allergic reaction. Symptoms may include sneezing, runny nose, itchy or watery eyes, and nasal congestion.
- Seasonal allergy: Also known as hay fever, this refers to allergic symptoms that occur during specific times of the year, typically when certain plants pollinate.
- Allergic asthma: Some patients with grass pollen allergies may also experience asthma symptoms. Beltavac may help control these symptoms when they're associated with grass pollen allergy.
Administration and Dosage
Beltavac is administered as a subcutaneous injection, which means it's injected just under the skin. The treatment follows a specific schedule:
- Initial dose: 0.2 ml in one arm and 0.3 ml in the other arm, given 30 minutes apart.
- Subsequent doses: A single injection of 0.5 ml per month for 5 months.
This schedule is designed to build up your tolerance gradually and safely. The entire treatment course typically lasts for about 24 weeks.
Effectiveness
The effectiveness of Beltavac is being studied in clinical trials. Researchers are looking at several factors to determine how well it works:
- Reduction in sensitivity to grass pollen, as measured by a Conjunctival Provocation Test (CPT).
- Improvement in nasal and eye symptoms during the peak pollen season.
- Reduction in the need for allergy medications during the pollen season.
Who Can Use Beltavac?
Beltavac is intended for adults aged 18 to 65 who have a confirmed grass pollen allergy. To be eligible for this treatment, patients typically need to meet several criteria:
- A history of moderate to severe allergic rhinoconjunctivitis due to grass pollen for at least two pollen seasons.
- Positive skin prick test and blood test results for grass pollen allergens.
- Good overall health, with normal liver and kidney function.
Patients with controlled asthma may also be eligible for Beltavac treatment.
Potential Side Effects and Precautions
As with any medical treatment, Beltavac may cause side effects. While specific side effects are not detailed in the provided information, patients should be aware that allergic reactions are possible with any immunotherapy treatment. It's crucial to discuss potential risks and side effects with your healthcare provider.
Certain individuals should not use Beltavac, including:
- Those with a history of severe allergic reactions or anaphylaxis.
- Patients with uncontrolled asthma or other serious respiratory conditions.
- Individuals with certain autoimmune diseases or immune deficiencies.
- Pregnant or breastfeeding women.
Always consult with your doctor to determine if Beltavac is suitable for you based on your individual health status and medical history.